Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Search

Decline in Youth E-Cigarette Use in US

Industry Insight by 2FIRSTS.ai
Nov.20.2023
Decline in Youth E-Cigarette Use in US
Teen e-cigarette use in the US hits lowest point in a decade, with 10% using fruit-flavored e-cigarettes in 2023, according to CDC.

According to a press release from Reuters on November 16th, a recent study report by the Centers for Disease Control and Prevention (CDC) in the United States revealed that the prevalence of e-cigarette use among American teenagers has reached its lowest point in nearly a decade. The proportion of teenagers using flavored e-cigarettes is projected to decrease from 14% in 2022 to 10% in 2023.

 

The significant drop in sales is related to the increase in e-cigarette prices and the policy of raising the minimum purchasing age to 21.

 

According to a study conducted in Brazil, approximately 2.2 million adults in the country regularly use e-cigarettes, and the number is on the rise.

 

References:
[1] Pesquisa aponta queda no consumo de cigarros eletrônicos entre os jovens americanos
Also Read:
[1] Impact of Menthol Cigarettes on African American Smokers
[2] E-cigarette Use Surpasses Traditional Cigarette Smoking Among American Youth
#E-cigarette#E-cigarettes and Tobacco#USA

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

INTER-TABAC
INTER-TABAC
Company | Philip Morris CEO: Expected profit growth in 2025 will be the highest in over a decade, with ZYN US retail sales up 32%
Company | Philip Morris CEO: Expected profit growth in 2025 will be the highest in over a decade, with ZYN US retail sales up 32%
At the 2025 Barclays Global Consumer Conference, Philip Morris International's CEO said that strong summer sales of IQOS and ZYN will boost the company's full-year 2025 adjusted EPS by 13% to 15%, the best performance since 2011 (excluding pandemic recovery). He also noted that IQOS has maintained strong growth in Q3, with ZYN sales up about 32% in the first eight weeks. The full-year shipment volume is expected to be between 800 million and 840 million cans.
Sep.03 by 2FIRSTS.ai
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
The U.S. FDA will launch a pilot program to accelerate reviews of nicotine pouch products from Philip Morris International, Altria, BAT’s Reynolds American, and Turning Point Brands, aiming to complete the process by December 2025. The move, driven by pressure from the Trump administration, seeks to address past multi-year approval delays. Nicotine pouches, the fastest-growing U.S. smoking alternative, are seen as lower-risk but raise youth appeal concerns.
Sep.08
Special Report | EU Cardiovascular Health Plan Consultation Sparks Debate on Regulation of Novel Tobacco Products, Potentially Shaping TPD III
Special Report | EU Cardiovascular Health Plan Consultation Sparks Debate on Regulation of Novel Tobacco Products, Potentially Shaping TPD III
The EU’s consultation on the Cardiovascular Health Plan, though not mentioning nicotine, has sparked debate over novel tobacco regulation. Advocates urge evidence-based recognition of harm reduction products, while opponents call for tighter rules. The plan may influence TPD III, drawing close scrutiny from both industry and health groups.
Sep.01
Company | JTI Executive: The company has invested over 300 million euros in Romania and created 1,500 jobs
Company | JTI Executive: The company has invested over 300 million euros in Romania and created 1,500 jobs
JTI has operated in Romania for over 30 years, investing over €300M and creating 1,500 jobs. It paid €1.3B in taxes in 2024. Executive Lucine Ovumyan recently told Antena 3 that the company contributes significantly to the economy but is concerned about a proposed EU tobacco tax directive. She said it could lead to a 59% tax increase over three years and fuel illegal trade. She called for balanced tax policies and dialogue to support growth, innovation, and fair competition.
Sep.02 by 2FIRSTS.ai
Comparing the UK's Approved E-cigarette Lists (June-August): E-liquids and pods remain the mainstays, while open-system devices saw an accelerated release of new products in August
Comparing the UK's Approved E-cigarette Lists (June-August): E-liquids and pods remain the mainstays, while open-system devices saw an accelerated release of new products in August
Based on the latest data from the MHRA, e-cigarette registrations in the UK showed a "peak in July, drop in August" trend. E-liquids and pods consistently made up about 90% of the total. While pre-filled pod systems were the most common, open-system device registrations notably increased in August.
Sep.04 by 2FIRSTS.ai
Philip Morris International Raises Dividend by 8.9% to an Annualized $5.88 per Share
Philip Morris International Raises Dividend by 8.9% to an Annualized $5.88 per Share
Philip Morris International (PMI) has increased its quarterly dividend from $1.35 to $1.47 per share, bringing the annualized dividend to $5.88. Since listing in 2008, PMI has raised its dividend for 17 consecutive years. The company continues to accelerate its “smoke-free future” strategy: in the first half of 2025, smoke-free products contributed 41% of net revenues, with over 41 million adult consumers using PMI’s smoke-free products globally.
Sep.24 by 2FIRSTS.ai
Related Topics
News
Related Read
Company | Philip Morris CEO: Expected profit growth in 2025 will be the highest in over a decade, with ZYN US retail sales up 32%
Company | Philip Morris CEO: Expected profit growth in 2025 will be the highest in over a decade, with ZYN US retail sales up 32%
2FIRSTS.ai
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
Special Report | EU Cardiovascular Health Plan Consultation Sparks Debate on Regulation of Novel Tobacco Products, Potentially Shaping TPD III
Special Report | EU Cardiovascular Health Plan Consultation Sparks Debate on Regulation of Novel Tobacco Products, Potentially Shaping TPD III
Company | JTI Executive: The company has invested over 300 million euros in Romania and created 1,500 jobs
Company | JTI Executive: The company has invested over 300 million euros in Romania and created 1,500 jobs
2FIRSTS.ai
Comparing the UK's Approved E-cigarette Lists (June-August): E-liquids and pods remain the mainstays, while open-system devices saw an accelerated release of new products in August
Comparing the UK's Approved E-cigarette Lists (June-August): E-liquids and pods remain the mainstays, while open-system devices saw an accelerated release of new products in August
2FIRSTS.ai
Philip Morris International Raises Dividend by 8.9% to an Annualized $5.88 per Share
Philip Morris International Raises Dividend by 8.9% to an Annualized $5.88 per Share
2FIRSTS.ai
FOLLOW US ON SOCIAL MEDIA
Contact: info@2firsts.com
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
© 2025 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit https://cn.2firsts.com
English
English
中文